Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus monotherapy in elderly kidney transplant recipients
NL-OMON60461Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2025
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in kidney transplant comparing Tacrolimus monotherapy with Tacrolimus plus prednisone maintenance (2 arms). Primary endpoints: Death by infectious disease and Infectious burden. Started Aug 2025; status: recruiting.
02
Drugs
tacrolimusprednisone
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON60461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60461.